Companies: 11,222     total market cap: A$219.204 T
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Marcus Corporation
MCS
#6433
Rank
A$1.36 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$44.15
Share price
1.30%
Change (1 day)
97.15%
Change (1 year)
๐Ÿจ Hotels Entertainment๐ŸŒด Travel
Categories
  1. Marcus Corporation
  2. Quarterly Reports (10-Q)
  3. Financial Year FY2026 Q2

Marcus Corporation - 10-Q quarterly report FY2026 Q2


Text size:
000006223412-312026Q2falsexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puremcs:agreementmcs:segment00000622342026-01-012026-06-300000062234us-gaap:CommonStockMember2026-07-270000062234us-gaap:CommonClassBMember2026-07-2700000622342026-06-3000000622342025-12-310000062234us-gaap:CommonStockMember2026-06-300000062234us-gaap:CommonStockMember2025-12-310000062234us-gaap:CommonClassBMember2025-12-310000062234us-gaap:CommonClassBMember2026-06-300000062234us-gaap:AdmissionMember2026-04-012026-06-300000062234us-gaap:AdmissionMember2025-04-012025-06-300000062234us-gaap:AdmissionMember2026-01-012026-06-300000062234us-gaap:AdmissionMember2024-12-272025-06-300000062234us-gaap:OccupancyMember2026-04-012026-06-300000062234us-gaap:OccupancyMember2025-04-012025-06-300000062234us-gaap:OccupancyMember2026-01-012026-06-300000062234us-gaap:OccupancyMember2024-12-272025-06-300000062234us-gaap:ConcessionsMember2026-04-012026-06-300000062234us-gaap:ConcessionsMember2025-04-012025-06-300000062234us-gaap:ConcessionsMember2026-01-012026-06-300000062234us-gaap:ConcessionsMember2024-12-272025-06-300000062234us-gaap:FoodAndBeverageMember2026-04-012026-06-300000062234us-gaap:FoodAndBeverageMember2025-04-012025-06-300000062234us-gaap:FoodAndBeverageMember2026-01-012026-06-300000062234us-gaap:FoodAndBeverageMember2024-12-272025-06-300000062234us-gaap:ProductAndServiceOtherMember2026-04-012026-06-300000062234us-gaap:ProductAndServiceOtherMember2025-04-012025-06-300000062234us-gaap:ProductAndServiceOtherMember2026-01-012026-06-300000062234us-gaap:ProductAndServiceOtherMember2024-12-272025-06-3000000622342026-04-012026-06-3000000622342025-04-012025-06-3000000622342024-12-272025-06-300000062234mcs:TheatreOperationsMember2026-04-012026-06-300000062234mcs:TheatreOperationsMember2025-04-012025-06-300000062234mcs:TheatreOperationsMember2026-01-012026-06-300000062234mcs:TheatreOperationsMember2024-12-272025-06-300000062234us-gaap:CommonStockMember2026-04-012026-06-300000062234us-gaap:CommonStockMember2025-04-012025-06-300000062234us-gaap:CommonStockMember2026-01-012026-06-300000062234us-gaap:CommonStockMember2024-12-272025-06-300000062234us-gaap:CommonClassBMember2026-04-012026-06-300000062234us-gaap:CommonClassBMember2025-04-012025-06-300000062234us-gaap:CommonClassBMember2026-01-012026-06-300000062234us-gaap:CommonClassBMember2024-12-272025-06-3000000622342024-12-2600000622342025-06-300000062234us-gaap:EmployeeStockOptionMember2026-04-012026-06-300000062234us-gaap:EmployeeStockOptionMember2025-04-012025-06-300000062234us-gaap:EmployeeStockOptionMember2026-01-012026-06-300000062234us-gaap:EmployeeStockOptionMember2024-12-272025-06-300000062234us-gaap:RestrictedStockUnitsRSUMember2026-04-012026-06-300000062234us-gaap:RestrictedStockUnitsRSUMember2025-04-012025-06-300000062234us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-06-300000062234us-gaap:RestrictedStockUnitsRSUMember2024-12-272025-06-300000062234us-gaap:PerformanceSharesMember2026-04-012026-06-300000062234us-gaap:PerformanceSharesMember2025-04-012025-06-300000062234us-gaap:PerformanceSharesMember2026-01-012026-06-300000062234us-gaap:PerformanceSharesMember2024-12-272025-06-300000062234us-gaap:CommonStockMember2025-12-310000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2025-12-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-12-310000062234us-gaap:RetainedEarningsMember2025-12-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000062234us-gaap:TreasuryStockCommonMember2025-12-310000062234us-gaap:ParentMember2025-12-310000062234us-gaap:CommonClassBMember2026-01-012026-03-310000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2026-01-012026-03-310000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2026-01-012026-03-310000062234us-gaap:CommonStockMember2026-01-012026-03-310000062234us-gaap:RetainedEarningsMember2026-01-012026-03-310000062234us-gaap:ParentMember2026-01-012026-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-01-012026-03-310000062234us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000062234us-gaap:CommonStockMember2026-03-310000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2026-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-03-310000062234us-gaap:RetainedEarningsMember2026-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000062234us-gaap:TreasuryStockCommonMember2026-03-310000062234us-gaap:ParentMember2026-03-310000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2026-04-012026-06-300000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2026-04-012026-06-300000062234us-gaap:RetainedEarningsMember2026-04-012026-06-300000062234us-gaap:ParentMember2026-04-012026-06-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-04-012026-06-300000062234us-gaap:TreasuryStockCommonMember2026-04-012026-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000062234us-gaap:CommonStockMember2026-06-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2026-06-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-06-300000062234us-gaap:RetainedEarningsMember2026-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300000062234us-gaap:TreasuryStockCommonMember2026-06-300000062234us-gaap:ParentMember2026-06-300000062234us-gaap:CommonStockMember2024-12-260000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-12-260000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-260000062234us-gaap:RetainedEarningsMember2024-12-260000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-260000062234us-gaap:TreasuryStockCommonMember2024-12-260000062234us-gaap:ParentMember2024-12-260000062234us-gaap:CommonClassBMember2024-12-272025-03-310000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2024-12-272025-03-310000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2024-12-272025-03-310000062234us-gaap:CommonStockMember2024-12-272025-03-310000062234us-gaap:RetainedEarningsMember2024-12-272025-03-310000062234us-gaap:ParentMember2024-12-272025-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-272025-03-310000062234us-gaap:TreasuryStockCommonMember2024-12-272025-03-310000062234us-gaap:CommonStockMember2024-12-272025-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-272025-03-310000062234us-gaap:CommonStockMember2025-03-310000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2025-03-310000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-03-310000062234us-gaap:RetainedEarningsMember2025-03-310000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000062234us-gaap:TreasuryStockCommonMember2025-03-310000062234us-gaap:ParentMember2025-03-310000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2025-04-012025-06-300000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2025-04-012025-06-300000062234us-gaap:RetainedEarningsMember2025-04-012025-06-300000062234us-gaap:ParentMember2025-04-012025-06-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-04-012025-06-300000062234us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000062234us-gaap:CommonStockMember2025-06-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2025-06-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-06-300000062234us-gaap:RetainedEarningsMember2025-06-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000062234us-gaap:TreasuryStockCommonMember2025-06-300000062234us-gaap:ParentMember2025-06-300000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2026-06-300000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-12-310000062234us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300000062234us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310000062234us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310000062234us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300000062234mcs:NotePurchaseAgreementMember2026-06-300000062234us-gaap:SeniorNotesMemberus-gaap:FairValueInputsLevel2Member2026-06-300000062234us-gaap:AdmissionMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:AdmissionMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:AdmissionMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:OccupancyMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:OccupancyMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:OccupancyMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:ConcessionsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:ConcessionsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:ConcessionsMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:FoodAndBeverageMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2026-04-012026-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2026-04-012026-06-300000062234us-gaap:CorporateNonSegmentMember2026-04-012026-06-300000062234us-gaap:AdmissionMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:AdmissionMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:AdmissionMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:OccupancyMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:OccupancyMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:OccupancyMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:ConcessionsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:ConcessionsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:ConcessionsMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:FoodAndBeverageMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2026-01-012026-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2026-01-012026-06-300000062234us-gaap:CorporateNonSegmentMember2026-01-012026-06-300000062234us-gaap:AdmissionMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:AdmissionMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:AdmissionMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:OccupancyMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:OccupancyMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:OccupancyMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:ConcessionsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:ConcessionsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:ConcessionsMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:FoodAndBeverageMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2025-04-012025-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2025-04-012025-06-300000062234us-gaap:CorporateNonSegmentMember2025-04-012025-06-300000062234us-gaap:AdmissionMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:AdmissionMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:AdmissionMemberus-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234us-gaap:OccupancyMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:OccupancyMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:OccupancyMemberus-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234us-gaap:ConcessionsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:ConcessionsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:ConcessionsMemberus-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234us-gaap:FoodAndBeverageMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:FoodAndBeverageMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2024-12-272025-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2024-12-272025-06-300000062234us-gaap:CorporateNonSegmentMember2024-12-272025-06-300000062234mcs:AdvancedSaleOfTicketsMember2026-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2026-06-300000062234mcs:AdvancedSaleOfTicketsMember2026-01-012026-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2026-06-300000062234us-gaap:RevolvingCreditFacilityMember2026-06-300000062234us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-10-162026-06-300000062234mcs:GreaterOfFederalFundsRateOrOvernightBankFundingRateMemberus-gaap:RevolvingCreditFacilityMember2023-10-162026-06-300000062234mcs:BasedUponNetLeverageRatioMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-10-162026-06-300000062234mcs:BasedUponNetLeverageRatioMemberus-gaap:RevolvingCreditFacilityMembermcs:OneMonthSecuredOvernightFinancingRateSOFRMember2023-10-162026-06-300000062234us-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2023-10-162026-06-300000062234us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-10-162026-06-300000062234us-gaap:RevolvingCreditFacilityMember2023-10-162026-06-300000062234mcs:ForFullFiscalQuarterIfMaterialAcquisitionIsConsummatedMemberus-gaap:RevolvingCreditFacilityMember2023-10-162026-06-300000062234mcs:NotePurchaseAgreementsMember2026-06-300000062234mcs:MasterNotePurchaseAgreementMember2026-06-300000062234mcs:NotePurchaseAgreementsMembersrt:MinimumMember2026-06-300000062234mcs:NotePurchaseAgreementsMembersrt:MaximumMember2026-06-300000062234us-gaap:SeniorNotesMembermcs:NotePurchaseAgreementsMember2026-06-300000062234mcs:DueWithinNext12MonthsMembermcs:NotePurchaseAgreementsMember2026-06-300000062234srt:MinimumMember2026-06-300000062234srt:MaximumMember2026-06-300000062234us-gaap:OperatingLeaseRightOfUseAsset2026-06-300000062234us-gaap:EmployeeStockOptionMember2025-12-310000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2025-12-310000062234us-gaap:PerformanceSharesMember2025-12-310000062234us-gaap:EmployeeStockOptionMember2026-01-012026-06-300000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2026-01-012026-06-300000062234us-gaap:PerformanceSharesMember2026-01-012026-06-300000062234us-gaap:EmployeeStockOptionMember2026-06-300000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2026-06-300000062234us-gaap:PerformanceSharesMember2026-06-300000062234mcs:NonVestedRestrictedStockRSUsAndPSUsMember2026-06-300000062234mcs:NonVestedRestrictedStockRSUsAndPSUsMember2026-01-012026-06-300000062234mcs:MarcusCorporationOmnibusIncentivePlanMember2025-05-070000062234mcs:MarcusCorporationOmnibusIncentivePlanMember2026-06-300000062234us-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234mcs:TheatreOperationsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234mcs:TheatreOperationsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234mcs:TheatreOperationsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234mcs:TheatreOperationsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234mcs:TheatreOperationsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234mcs:TheatreOperationsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:OccupancyMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:OccupancyMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:ConcessionsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:ConcessionsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000062234us-gaap:CorporateNonSegmentMember2026-06-300000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2025-06-300000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2025-06-300000062234us-gaap:CorporateNonSegmentMember2025-06-300000062234us-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234mcs:TheatreOperationsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234mcs:TheatreOperationsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234mcs:TheatreOperationsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234mcs:TheatreOperationsMembermcs:TheatresMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234mcs:TheatreOperationsMembermcs:HotelsResortsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234mcs:TheatreOperationsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:OccupancyMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:OccupancyMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:ConcessionsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:ConcessionsMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000062234us-gaap:FoodAndBeverageMemberus-gaap:OperatingSegmentsMember2024-12-272025-06-30
Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2026
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 1-12604
THE MARCUS CORPORATION
(Exact name of registrant as specified in its charter)
Wisconsin39-1139844
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
111 East Kilbourn Avenue, Suite 1200
Milwaukee, Wisconsin
53202-6628
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (414) 905-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par valueMCSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.
Yeso Nox
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
YesxNoo
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check One).
Large accelerated fileroAccelerated filerx
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YesoNox
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
COMMON STOCK OUTSTANDING AT JULY 27, 2026 – 23,847,575
CLASS B COMMON STOCK OUTSTANDING AT JULY 27, 2026 –6,984,584

Table of Contents


THE MARCUS CORPORATION
INDEX
Page
Item 1.
3
5
6
7
8
Item 2.
15
Item 3.
25
Item 4.
25
Item 1A.
27
Item 2.
27
Item 4.
27
Item 5.
27
Item 6.
27
S-1
2
Table of Contents


PART I – FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
THE MARCUS CORPORATION
Consolidated Balance Sheets
(in thousands, except share and per share data)
June 30,
2026		December 31,
2025
ASSETS
Current assets:
Cash and cash equivalents$26,345 $23,448 
Restricted cash4,642 3,134 
Accounts receivable, net of reserves of $289 and $209, respectively
19,780 19,082 
Other current assets20,951 18,912 
Total current assets71,718 64,576 
Property and equipment:
Land and improvements148,172 142,063 
Buildings and improvements751,823 744,861 
Leasehold improvements167,054 165,646 
Furniture, fixtures and equipment454,073 448,196 
Finance lease right-of-use assets30,723 30,675 
Construction in progress10,155 15,376 
Total property and equipment1,562,000 1,546,817 
Less accumulated depreciation and amortization880,201 849,105 
Net property and equipment681,799 697,712 
Operating lease right-of-use assets139,148 142,115 
Other assets:
Investments in joint ventures3,797 4,486 
Goodwill74,996 74,996 
Deferred income taxes3,568 6,449 
Other24,523 24,198 
Total other assets106,884 110,129 
TOTAL ASSETS$999,549 $1,014,532 
See accompanying condensed notes to consolidated financial statements.
3
Table of Contents


THE MARCUS CORPORATION
Consolidated Balance Sheets
(in thousands, except share and per share data)
June 30,
2026		December 31,
2025
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable$42,957 $44,523 
Income taxes836 — 
Taxes other than income taxes18,597 18,482 
Accrued compensation22,129 23,562 
Other accrued liabilities61,257 57,828 
Current portion of finance lease obligations2,471 2,827 
Current portion of operating lease obligations16,501 16,219 
Total current liabilities164,748 163,441 
Finance lease obligations7,499 8,452 
Operating lease obligations144,394 148,977 
Long-term debt149,116 159,007 
Deferred income taxes32,295 30,905 
Other long-term obligations44,613 46,372 
Shareholders’ Equity:
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued
— — 
Common Stock, $1 par; authorized 50,000,000 shares; issued 25,369,054 shares at June 30, 2026 and 25,369,054 shares at December 31, 2025
25,369 25,369 
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 6,984,584 shares at June 30, 2026 and 6,984,584 shares at December 31, 2025
6,985 6,985 
Capital in excess of par186,141 184,002 
Retained earnings264,233 268,561 
Accumulated other comprehensive loss(18)(12)
482,710 484,905 
Less cost of Common Stock in treasury (1,569,624 shares at June 30, 2026 and 1,713,780 shares at December 31, 2025)
(25,826)(27,527)
Total shareholders’ equity456,884 457,378 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$999,549 $1,014,532 
See accompanying condensed notes to consolidated financial statements.
4
Table of Contents


THE MARCUS CORPORATION
Consolidated Statements of Operations
(in thousands, except per share data)
Three Months EndedSix Months Ended
June 30,
2026		June 30,
2025		June 30,
2026		June 30,
2025
Revenues:
Theatre admissions$72,557 $62,348 $117,382 $103,279 
Rooms33,706 29,632 54,168 48,907 
Theatre concessions65,264 57,611 104,829 95,611 
Food and beverage22,509 21,291 39,969 39,120 
Other revenues26,674 24,790 48,368 47,664 
220,710 195,672 364,716 334,581 
Cost reimbursements11,034 10,371 21,432 20,228 
Total revenues231,744 206,043 386,148 354,809 
Costs and expenses:
Theatre operations70,525 64,172 121,254 113,842 
Rooms11,785 11,086 22,103 20,992 
Theatre concessions26,180 23,337 43,350 40,788 
Food and beverage16,697 15,656 31,753 30,285 
Advertising and marketing6,774 6,644 12,509 11,888 
Administrative23,691 22,972 49,002 47,688 
Depreciation and amortization17,350 17,603 35,185 35,441 
Rent6,358 6,354 12,545 12,571 
Property taxes4,055 4,328 8,337 8,737 
Other operating expenses10,115 10,332 20,678 20,938 
Loss (gain) on disposition of property, equipment and other assets113 181 194 (1,184)
Reimbursed costs11,034 10,371 21,432 20,228 
Total costs and expenses204,677 193,036 378,342 362,214 
Operating income (loss)27,067 13,007 7,806 (7,405)
Other income (expense):
Investment income 66 409 86 483 
Interest expense(2,734)(2,981)(5,364)(5,803)
Other income (expense)(393)(443)(840)(887)
Equity earnings (losses) from unconsolidated joint ventures(15)75 (689)(495)
(3,076)(2,940)(6,807)(6,702)
Earnings (loss) before income taxes23,991 10,067 999 (14,107)
Income tax expense (benefit)8,147 2,746 508 (4,612)
Net earnings (loss)$15,844 $7,321 $491 $(9,495)
Net earnings (loss) per share - basic:
Common Stock$0.53 $0.24 $0.02 $(0.31)
Class B Common Stock$0.48 $0.22 $0.02 $(0.28)
Net earnings (loss) per share - diluted:
Common Stock$0.51 $0.23 $0.02 $(0.31)
Class B Common Stock$0.48 $0.22 $0.02 $(0.28)
See accompanying condensed notes to consolidated financial statements.
5
Table of Contents


THE MARCUS CORPORATION
Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
Three Months EndedSix Months Ended
June 30,
2026		June 30,
2025		June 30,
2026		June 30,
2025
Net earnings (loss)$15,844 $7,321 $491 $(9,495)
Other comprehensive loss, net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax benefit of $1, $1, $2 and $3, respectively
(3)(4)(6)(8)
Other comprehensive loss(3)(4)(6)(8)
Comprehensive earnings (loss)$15,841 $7,317 $485 $(9,503)
See accompanying condensed notes to consolidated financial statements.
6
Table of Contents


THE MARCUS CORPORATION
Consolidated Statements of Cash Flows
(in thousands)
Six Months Ended
June 30, 2026June 30, 2025
OPERATING ACTIVITIES:
Net earnings (loss)$491 $(9,495)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Losses on investments in joint ventures689 495 
Distribution from joint venture— 68 
Loss (gain) on disposition of property, equipment and other assets194 (1,184)
Proceeds from sale of historic tax credits2,975 — 
Depreciation and amortization35,185 35,441 
Amortization of debt issuance costs281 314 
Share-based compensation5,450 4,986 
Deferred income taxes(550)(5,870)
Changes in operating assets and liabilities:
Accounts receivable(698)(1,267)
Other assets(1,402)(6,437)
Operating leases (1,334)(1,053)
Accounts payable(2,968)(13,679)
Income taxes881 1,132 
Taxes other than income taxes115 (204)
Accrued compensation(1,433)(8,233)
Other accrued liabilities3,428 1,116 
   Other long-term obligations(2,562)181 
Total adjustments38,251 5,806 
Net cash provided by (used in) operating activities38,742 (3,689)
INVESTING ACTIVITIES:
Capital expenditures(16,649)(39,915)
Proceeds from disposals of property, equipment and other assets156 212 
Proceeds from sale of trading securities— 8,187 
Other investing activities18 (29)
Net cash used in investing activities(16,475)(31,545)
FINANCING ACTIVITIES:
Debt transactions:
Proceeds from borrowings on revolving credit facility82,000 105,000 
Repayment of borrowings on revolving credit facility(92,000)(84,000)
Principal payments on long-term debt— (392)
Principal payments on finance lease obligations(1,433)(1,323)
Equity transactions:
Treasury stock transactions, except for stock options(2,700)(7,612)
Exercise of stock options1,090 10 
Dividends paid(4,819)(4,329)
Net cash provided by (used in) financing activities(17,862)7,354 
Net increase (decrease) in cash, cash equivalents and restricted cash4,405 (27,880)
Cash, cash equivalents and restricted cash at beginning of period26,582 44,579 
Cash, cash equivalents and restricted cash at end of period$30,987 $16,699 
Supplemental Information:
Interest paid, net of amounts capitalized$5,057 $5,356 
Income taxes paid 177 125 
Change in accounts payable for additions to property, equipment and other assets1,402 (336)
See accompanying condensed notes to consolidated financial statements.
7
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)



1. General
Basis of Presentation - The unaudited consolidated financial statements for the three and six months ended June 30, 2026 and June 30, 2025 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 30, 2026, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Beginning on December 27, 2024, the Company’s fiscal year changed from a 52- or 53-week fiscal year ending on the last Thursday in December of each year to a fiscal year ending on December 31 of each year. Accordingly, effective for its fiscal year ended December 31, 2025 and thereafter, the Company’s quarterly results are for three month periods ending March 31, June 30, September 30 and December 31 of each year. In this quarterly report, the six months ended June 30, 2025 refers to the period December 27, 2024 through June 30, 2025.
Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 31, 2025, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.
Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $17,114 and $34,942, respectively, for the three and six months ended June 30, 2026, and $17,597 and $35,428, respectively, for the three and six months ended June 30, 2025.
Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset.
Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value.
Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the six months ended June 30, 2026 or June 30, 2025.
Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options, restricted stock units, and performance stock units using the if-converted method. Convertible Class B Common Stock is reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.
Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.
The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:
Three Months EndedSix Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
Net earnings (loss) per share - basic:
Common Stock$0.53 $0.24 $0.02 $(0.31)
Class B Common Stock$0.48 $0.22 $0.02 $(0.28)
Net earnings (loss) per share - diluted:
Common Stock$0.51 $0.23 $0.02 $(0.31)
Class B Common Stock$0.48 $0.22 $0.02 $(0.28)
Numerator:
Net earnings (loss)$15,844 $7,321 $491 $(9,495)
Denominator (in thousands):
Denominator for basic EPS30,733 31,304 30,707 31,453 
Effect of dilutive employee stock options212 47 146 — 
Effect of restricted stock units104 80 98 — 
Diluted weighted-average shares outstanding31,049 31,431 30,951 31,453 
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):
Employee stock options1,510 2,215 1,527 1,829 
Restricted stock units— — — 72 
Performance stock units375 238 344 213 
Total1,885 2,453 1,871 2,114 
For the periods when the Company reports a net loss, common stock equivalents, restricted stock units, and performance stock units are excluded from the computation of diluted loss per share as their inclusion would have an anti-dilutive effect. Performance stock units are considered anti-dilutive if the performance targets upon which the issuance of the shares are contingent have not been achieved and the respective performance period has not been completed as of the end of the current period.

Shareholders’ Equity - Activity impacting total shareholders’ equity for the six months ended June 30, 2026 and June 30, 2025 was as follows:
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Total Shareholders’
Equity
BALANCES AT DECEMBER 31, 2025$25,369 $6,985 $184,002 $268,561 $(12)$(27,527)$457,378 
Cash dividends:
$0.073 per share Class B Common Stock
— — — (510)— — (510)
$0.08 per share Common Stock
— — — (1,900)— — (1,900)
Exercise of stock options— — — — — 45 45 
Purchase of treasury stock— — — — — (2,331)(2,331)
Reissuance of treasury stock— — (313)— — 330 17 
Issuance of non-vested stock— — (2,429)— — 2,429 — 
Share-based compensation— — 3,824 — — — 3,824 
Comprehensive loss— — — (15,353)(3)— (15,356)
BALANCES AT MARCH 31, 202625,369 6,985 185,084 250,798 (15)(27,054)441,167 
Cash dividends:
$0.073 per share Class B Common Stock
— — — (510)— — (510)
$0.08 per share Common Stock
— — — (1,899)— — (1,899)
Exercise of stock options— — (274)— — 3,014 2,740 
Purchase of treasury stock— — — — — (2,097)(2,097)
Reissuance of treasury stock— — (13)— — 29 16 
Issuance of non-vested stock— — (282)— — 282 — 
Shared-based compensation— — 1,626 — — — 1,626 
Comprehensive income (loss)— — — 15,844 (3)— 15,841 
BALANCES AT JUNE 30, 202625,369 6,985 186,141 264,233 (18)(25,826)456,884 
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Total Shareholders’
Equity
BALANCES AT DECEMBER 26, 2024$25,237 $6,985 $177,172 $265,028 $(181)$(9,375)$464,866 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.07 per share Common Stock
— — — (1,733)— — (1,733)
Exercise of stock options— — 1 — — 7 8 
Purchase of treasury stock— — — — — (7,642)(7,642)
Reissuance of treasury stock— — 1 — — 13 14 
Issuance of non-vested stock132 — (208)— — 76 — 
Share-based compensation— — 3,545 — — — 3,545 
Comprehensive loss— — — (16,816)(4)— (16,820)
BALANCES AT MARCH 31, 202525,369 6,985 180,511 246,032 (185)(16,921)441,791 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.07 per share Common Stock
— — — (1,702)— — (1,702)
Exercise of stock options— — — — — 2 2 
Purchase of treasury stock— — — — — — — 
Reissuance of treasury stock— — 1 — — 15 16 
Issuance of non-vested stock— — (265)— — 265 — 
Shared-based compensation— — 1,441 — — — 1,441 
Comprehensive income (loss)— — — 7,321 (4)— 7,317 
BALANCES AT JUNE 30, 202525,369 6,985 181,688 251,204 (189)(16,639)448,418 
Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
June 30,
2026		December 31,
2025
Net unrecognized actuarial loss for pension obligation$(18)$(12)
$(18)$(12)
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.
The Company’s assets and liabilities measured at fair value are classified in one of the following categories:
Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 30, 2026 and December 31, 2025, the Company had $12,000 and $10,000, respectively, of investments in money market funds which were valued using Level 1 pricing inputs and were included in cash and cash equivalents.
Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At each of June 30, 2026 and December 31, 2025, none of the Company’s recorded assets or liabilities were measured using Level 2 pricing inputs.
Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At each of June 30, 2026 and December 31, 2025, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets that are measured on a non-recurring basis are discussed above under Long-Lived Assets.
The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $150,000 of senior notes, valued using Level 2 pricing inputs, is approximately $153,523 at June 30, 2026, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.
Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
Three Months EndedSix Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
Service cost$55 $50 $109 $100 
Interest cost467 463 934 927 
Net amortization of prior service cost and actuarial loss(4)(5)(8)(11)
Net periodic pension cost$518 $508 $1,035 $1,016 
Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of operations.
Revenue Recognition – The disaggregation of revenues by business segment for the three and six months ended June 30, 2026 is as follows:
Three Months Ended June 30, 2026
TheatresHotels/Resorts CorporateTotal
Theatre admissions$72,557 $— $— $72,557 
Rooms— 33,706 — 33,706 
Theatre concessions65,264 — — 65,264 
Food and beverage— 22,509 — 22,509 
Other revenues(1)
12,025 14,537 112 26,674 
  Revenue before cost reimbursements149,846 70,752 112 220,710 
Cost reimbursements802 10,232 — 11,034 
Total revenues$150,648 $80,984 $112 $231,744 
Six Months Ended June 30, 2026
TheatresHotels/ResortsCorporateTotal
Theatre admissions$117,382 $— $— $117,382 
Rooms— 54,168 — 54,168 
Theatre concessions104,829 — — 104,829 
Food and beverage— 39,969 — 39,969 
Other revenues(1)
19,849 28,334 185 48,368 
  Revenue before cost reimbursements242,060 122,471 185 364,716 
Cost reimbursements1,516 19,916 — 21,432 
Total revenues$243,576 $142,387 $185 $386,148 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The disaggregation of revenues by business segment for the three and six months ended June 30, 2025 is as follows:
Three Months Ended June 30, 2025
TheatresHotels/ResortsCorporateTotal
Theatre admissions$62,348 $— $— $62,348 
Rooms— 29,632 — 29,632 
Theatre concessions57,611 — — 57,611 
Food and beverage— 21,291 — 21,291 
Other revenues(1)
11,045 13,634 111 24,790 
  Revenue before cost reimbursements131,004 64,557 111 195,672 
Cost reimbursements646 9,725 — 10,371 
Total revenues$131,650 $74,282 $111 $206,043 
Six Months Ended June 30, 2025
TheatresHotels/ResortsCorporateTotal
Theatre admissions$103,279 $— $— $103,279 
Rooms— 48,907 — 48,907 
Theatre concessions95,611 — — 95,611 
Food and beverage— 39,120 — 39,120 
Other revenues(1)
18,636 28,830 198 47,664 
  Revenue before cost reimbursements217,526 116,857 198 334,581 
Cost reimbursements1,481 18,747 — 20,228 
Total revenues$219,007 $135,604 $198 $354,809 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The Company had deferred revenue from contracts with customers of $42,995 and $39,475 as of June 30, 2026 and December 31, 2025, respectively. The Company had no contract assets as of June 30, 2026 and December 31, 2025. During the six months ended June 30, 2026, the Company recognized revenue of $13,852 that was included in deferred revenues as of December 31, 2025. During the six months ended June 30, 2025, the Company recognized revenue of $12,448 that was included in deferred revenues as of December 26, 2024. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced sales and the Company’s loyalty program.
As of June 30, 2026, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $1,748 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of June 30, 2026, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $12,124 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.
As of June 30, 2026, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,472 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.
The majority of the Company’s revenue is recognized in less than one year from the original contract.
Recent Accounting Pronouncements - On November 4, 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (DISE), which requires disaggregated disclosure of income statement expenses for public business entities. ASU No. 2024-03 does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU No. 2024-03 is effective for the Company in fiscal 2027. The Company is evaluating the effect the guidance will have on its consolidated financial statement disclosures.
On September 18, 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal use Software (Subtopic 350-50): Targeted Improvements to the Accounting for Internal-Use Software (ASU No. 2025-06), which simplifies the capitalization guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. ASU No. 2025-06 also supersedes the current website development costs guidance and incorporates the recognition requirements for website-specific development costs from ASC 350-50 into ASC 350-40. ASU 2025-06 is effective for the Company in fiscal 2028. The Company is evaluating the effect the guidance will have on its consolidated financial statements.
On December 4, 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes recognition, measurement, and presentation guidance for government grants received by business entities. Under the new guidance, government grants are recognized when there is reasonable assurance that the Company will comply with the conditions of the grant and that the grant will be received. Grants related to income are presented either as other income or as a reduction of the related expense, while grants related to assets are recorded either as deferred income or as a reduction of the carrying amount of the related asset. The guidance in this ASU is effective for fiscal years beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. If a business entity adopts the amendments in this ASU in an interim reporting period, it must adopt them as of the beginning of the annual reporting period that includes that interim reporting period. The Company elected to early adopt this guidance in fiscal 2026, applying a modified prospective approach. The Company has elected to recognize the government grant utilizing the deferred income approach. The adoption did not have a material impact on the Company's condensed consolidated financial statements.

2. Long-Term Debt
Long-term debt is summarized as follows:
June 30, 2026December 31, 2025
Senior notes$150,000 $150,000 
Revolving credit agreement— 10,000 
Total debt150,000 160,000 
Debt issuance costs(884)(993)
Total debt, net of debt issuance costs149,116 159,007 
Long-term debt$149,116 $159,007 
Credit Agreement
As of June 30, 2026, the Company has a Credit Agreement that provides for a revolving credit facility that matures on October 16, 2028 with an initial maximum aggregate amount of availability of $225,000. At June 30, 2026, there were no borrowings outstanding on the revolving credit facility, which when borrowed, bear interest at the secured overnight financing rate (SOFR) plus a margin (as discussed further below), approximately 5.39% at June 30, 2026. Availability
8
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


under the $225,000 revolving credit facility was $219,286 as of June 30, 2026 after taking into consideration outstanding letters of credit that reduce revolver availability.
Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) the term SOFR, plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date, or (ii) the alternate base rate (“ABR”) (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date. The revolving credit facility also requires an annual facility fee equal to 0.175% to 0.275% of the total revolving commitments depending on the Company’s consolidated net leverage ratio.
The Credit Agreement includes, among other restrictions and covenants applicable to the Company, a requirement that the Company’s consolidated net leverage ratio not exceed 3.50:1.00, provided that, with some limitations, such ratio may be increased to 4.00:1.00 for the full fiscal quarter in which a material acquisition (in which aggregate consideration equals or exceeds $30,000) is consummated and the three fiscal quarters immediately thereafter, and a requirement that the Company’s interest coverage ratio at the end of any fiscal quarter not be less than 3.00:1.00.
In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement.
The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.
Note Purchase Agreements
As of June 30, 2026, the Company’s $150,000 of senior notes consisted of one Note Purchase Agreement and one Master Note Purchase Agreement (collectively the “Senior Notes Agreements”) maturing in 2027 through 2034, which require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.32% to 7.02%. The weighted average fixed rate of the $150,000 senior notes was 6.07% as of June 30, 2026.
As of June 30, 2026, $50,000 of senior notes are due within the next 12 months. As of June 30, 2026, in accordance with Accounting Standards Codification (“ASC”) 470 Debt, our intent to refinance such debt on a long-term basis and our ability to refinance the obligation through the then-available capacity of the Credit Agreement resulted in the senior notes due within the next 12 months being classified as long-term debt.
3. Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to ASC 842, Leases. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
9
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


Total lease cost consists of the following:
Three Months EndedSix Months Ended
Lease CostClassificationJune 30, 2026June 30, 2025June 30, 2026June 30, 2025
Finance lease costs: 
Amortization of finance lease assetsDepreciation and amortization$625 $602 $1,246 $1,152 
Interest on lease liabilitiesInterest expense124 152 255 302 
$749 $754 $1,501 $1,454 
Operating lease costs:
Operating lease costsRent expense$5,596 $5,759 $11,214 $11,528 
Variable lease costRent expense715 544 1,236 947 
Short-term lease costRent expense47 51 95 96 
$6,358 $6,354 $12,545 $12,571 
Additional information related to leases is as follows:
Six Months Ended
Other InformationJune 30, 2026June 30, 2025
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases$1,433 $1,323 
Operating cash flows from finance leases255 302 
Operating cash flows from operating leases12,718 12,804 
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities125 757 
Operating lease liabilities4,588 1,261 
June 30, 2026December 31, 2025
Finance leases:
Property and equipment – gross$30,723 $30,675 
Accumulated depreciation and amortization(22,520)(21,350)
Property and equipment - net$8,203 $9,325 
10
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


Remaining lease terms and discount rates are as follows:
Lease Term and Discount RateJune 30, 2026December 31, 2025
Weighted-average remaining lease terms:
Finance leases5 years5 years
Operating leases10 years10 years
Weighted-average discount rates:
Finance leases4.75 %4.76 %
Operating leases4.83 %4.80 %
Deferred rent payments of approximately $393 for the Company’s operating leases have been included in the total operating lease obligations as of June 30, 2026, none of which is included in long-term operating lease obligations.
4. Share-Based Compensation
During the six months ended June 30, 2026, the Company granted restricted stock, restricted stock units (RSUs) and performance stock units (PSUs) to certain executives and associates. A summary of the Company’s stock option, restricted stock, RSU and PSU activity follows, with PSUs reflected at the target achievement percentage until the completion of the performance period (shares in thousands).
Stock OptionsRestricted Stock & RSUsPSUs
OptionsWeighted-Average Exercise PriceShares / UnitsWeighted-Average Fair ValueUnitsWeighted-Average Fair Value
December 31, 20252,709 $23.38 825 $15.85 233 $17.80 
Granted — — 255 16.15 153 16.15 
Exercised (1)
(166)16.79 — — — — 
Vested (2)
— — (184)15.79 — — 
Forfeited(92)19.01 (2)19.50 (14)17.74 
June 30, 20262,451 $24.00 894 $16.65 372 $17.12 
(1)Exercise activity only applicable to stock options.
(2)Vesting activity not applicable to stock options.
Share-based compensation expense was $1,626 and $5,450, respectively, during the three and six months ended June 30, 2026, and $1,441 and $4,986, respectively, during the three and six months ended June 30, 2025. As of June 30, 2026, total unrecognized share-based compensation expense related to stock options was $325, which will be amortized to expense over the weighted-average remaining life of 0.8 years. As of June 30, 2026, total unrecognized share-based compensation expense related to non-vested restricted stock, RSUs and PSUs was $7,720, which will be amortized over the weighted-average remaining service period of 1.9 years.
Shareholders of The Marcus Corporation approved the adoption of the Marcus Corporation Omnibus Incentive Plan effective May 7, 2025 and authorized 2,000,000 shares available for issuance under the plan. At June 30, 2026, there were 1,612,447 shares available for grants of various equity awards under the plan.
5. Income Taxes
The Company’s effective income tax rate for the three and six months ended June 30, 2026 was 33.9% and 50.8%, respectively, and was 27.3% and 32.7% for the three and six months ended June 30, 2025. The effective income tax rates in
11
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


both the three and six months ended June 30, 2026 were negatively impacted by excess compensation subject to deduction limitations. The effective income tax rate for the six months ended June 30, 2026 was impacted by discrete tax items primarily related to the exercise of stock options.
6. Business Segment Information
The Company’s primary operations are reported in the following two business segments: movie theatres and hotels and resorts. The Marcus Corporation’s chief operating decision maker (CODM) is the Company’s Chief Executive Officer. The measure of segment profit and loss the CODM uses to evaluate performance is operating income of each segment. The CODM uses this measure to evaluate trends and assess segment operating performance as compared to budget, historical periods, the industries each segment operates in and their competition in order to determine how to allocate resources to each segment. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies.

12
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


Following is a summary of business segment information for the three and six months ended June 30, 2026 and June 30, 2025:
Three Months Ended June 30, 2026Three Months Ended June 30, 2025
TheatresHotels/ResortsTotalTheatresHotels/ResortsTotal
Total Revenues$150,648 $80,984 $231,632 $131,650 $74,282 $205,932 
Less: Costs and expenses
Theatre operations70,525 — 70,525 64,172 — 64,172 
Rooms— 11,785 11,785 — 11,086 11,086 
Theatre concessions26,180 — 26,180 23,337 — 23,337 
Food and beverage— 16,697 16,697 — 15,656 15,656 
Advertising and marketing1,575 5,158 6,733 1,794 4,804 6,598 
Administrative6,369 11,527 17,896 5,852 10,817 16,669 
Depreciation and amortization9,699 7,268 16,967 10,455 6,746 17,201 
Rent5,811 443 6,254 5,783 467 6,250 
Property taxes2,503 1,519 4,022 2,847 1,453 4,300 
Reimbursed costs802 10,232 11,034 647 9,724 10,371 
Other segment items (1)
529 9,651 10,180 1,063 9,335 10,398 
Total costs and expenses123,993 74,280 198,273 115,950 70,088 186,038 
Operating income$26,655 $6,704 $33,359 $15,700 $4,194 $19,894 
Investment income (loss)66 409 
Interest expense(2,734)(2,981)
Other income (expense), net(393)(443)
Equity earnings (losses) from unconsolidated joint ventures, net(15)75 
Corporate items (2)
(6,292)(6,887)
Net income before income taxes$23,991 $10,067 
Three Months Ended June 30, 2026Three Months Ended June 30, 2025
TheatresHotels/
Resorts
Corporate
Items (2)
TotalTheatresHotels/
Resorts
Corporate
Items (2)
Total
Additional Disclosures
Share-based compensation247 324 1,055 $1,626 $187 $274 $980 $1,441 
Capital expenditures6,290 3,526 185 10,001 6,065 10,718 127 16,910 
Assets600,732 333,641 65,176 999,549 627,857 333,075 55,375 1,016,307 
13
Table of Contents
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026
(in thousands, except share and per share data)


Six Months Ended June 30, 2026Six Months Ended June 30, 2025
TheatresHotels/ResortsTotalTheatresHotels/ResortsTotal
Total Revenues$243,576 $142,387 $385,963 $219,007 $135,604 $354,611 
Less: Costs and expenses
Theatre operations121,254 — 121,254 113,842 — 113,842 
Rooms— 22,103 22,103 — 20,992 20,992 
Theatre concessions43,350 — 43,350 40,788 — 40,788 
Food and beverage— 31,753 31,753 — 30,285 30,285 
Advertising and marketing2,810 9,566 12,376 2,938 8,868 11,806 
Administrative12,805 22,484 35,289 11,777 22,079 33,856 
Depreciation and amortization19,963 14,455 34,418 21,161 13,482 34,643 
Rent11,414 921 12,335 11,435 928 12,363 
Property taxes5,220 3,050 8,270 5,738 2,924 8,662 
Reimbursed costs1,516 19,916 21,432 1,481 18,747 20,228 
Other segment items (1)
1,400 19,365 20,765 428 19,149 19,577 
Total costs and expenses219,732 143,613 363,345 209,588 137,454 347,042 
Operating income (loss)$23,844 $(1,226)$22,618 $9,419 $(1,850)$7,569 
Investment income86 483 
Interest expense(5,364)(5,803)
Other income (expense), net(840)(887)
Equity losses from unconsolidated joint ventures, net(689)(495)
Corporate items (2)
(14,812)(14,974)
Net income (loss) before income taxes$999 $(14,107)
Six Months Ended June 30, 2026Six Months Ended June 30, 2025
TheatresHotels/
Resorts
Corporate
Items (2)
TotalTheatresHotels/
Resorts
Corporate
Items (2)
Total
Additional Disclosures
Share-based compensation$736 $661 $4,053 $5,450 $683 $596 $3,707 $4,986 
Capital expenditures10,071 6,249 329 16,649 10,424 26,621 2,870 39,915 
Assets600,732 333,641 65,176 999,549 627,857 333,075 55,375 1,016,307 
(1) Other segment items includes losses or gains on disposition of property, equipment and other assets, preopening expenses, and other operating expenses.
(2) Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. Corporate assets primarily include cash and cash equivalents, furniture, fixtures and equipment, investments and land held for development.
14
Table of Contents
THE MARCUS CORPORATION
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Quarterly Report on Form 10-Q and the accompanying Management’s Discussion and Analysis, are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects future pandemics or epidemics may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (including disruptions in the production of films due to events such as tariffs or a strike by actors, writers or directors or future pandemics); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of tariffs that are implemented or merely threatened on our costs; (12) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (13) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (14) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States or other incidents of violence in public venues such as hotels and movie theatres; and (15) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
RESULTS OF OPERATIONS
General
For fiscal 2024 and prior periods, we reported our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December, dividing our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. Fiscal 2024 was a 52-week year with 364 operating days, beginning on December 29, 2023 and ending on December 26, 2024.
Beginning on December 27, 2024, our fiscal year changed to a calendar fiscal year ending on December 31 of each year. Accordingly, effective for our fiscal year ending December 31, 2025, our quarterly results were three month periods ending March 31, June 30, September 30 and December 31. Fiscal 2025 was a 370 operating day year beginning on December 27, 2024 and ending on December 31, 2025 (comprised of five operating days between December 27-31, 2024, plus 365 operating days in calendar year 2025). Fiscal 2026 is a 365 operating day year beginning on January 1, 2026 and ending on December 31, 2026.
15
Table of Contents
The second quarter of 2026 and 2025 consisted of the three month periods beginning on April 1 and ended on June 30. The first half of fiscal 2026 consisted of the six month period beginning on January 1, 2026 and ended on June 30, 2026 and included five fewer operating days compared to the prior year fiscal first half. The first half of fiscal 2025 consisted of the period beginning on December 27, 2024 and ended on June 30, 2025 (comprised of five operating days between December 27-31, 2024, plus 181 operating days in the calendar first half of 2025).
Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.
Overall Results
The following table sets forth revenues, operating income (loss), other income (expense), net earnings (loss), and net earnings (loss) per diluted common share for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for per share and variance percentage data):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct.F2026F2025Amt.Pct.
Revenues$231.7 $206.0 $25.7 12.5 %$386.1 $354.8 $31.3 8.8 %
Operating income (loss)27.1 13.0 14.1 108.1 %7.8 (7.4)15.2 205.4 %
Other income (expense)(3.1)(2.9)(0.1)(4.6)%(6.8)(6.7)(0.1)(1.6)%
Net earnings (loss)$15.8 $7.3 $8.5 116.4 %$0.5 $(9.5)$10.0 105.2 %
Net earnings (loss) per common share - diluted$0.51 $0.23 $0.28 121.7 %$0.02 $(0.31)$0.33 106.5 %
Revenues increased during the second quarter and first half of fiscal 2026 compared to the second quarter and first half of fiscal 2025 due to increased revenues from both our theatre division and hotels and resorts division. First half revenues increased despite the fact that the first half of fiscal 2026 included five less operating days compared to the first half of fiscal 2025, negatively impacting revenue growth by approximately $15.3 million.
Operating income during the second quarter of fiscal 2026 improved by $14.1 million compared to the second quarter of fiscal 2025, primarily due to increased revenues before cost reimbursements from both our theatre division and hotels and resorts division, a $0.6 million decrease in corporate expenses and a $0.3 million decrease in depreciation expense. Operating income (loss) during the first half of fiscal 2026 improved by $15.2 million compared to the first half of fiscal 2025 due to increased revenues from both our theatre and hotels and resorts divisions, decreased corporate expenses, and a $0.3 million decrease in depreciation expense, partially offset by a $5.3 million unfavorable impact as a result of five fewer operating days. Operating income (loss) during the first half of fiscal 2026 was negatively impacted by a $0.2 million loss on disposition of property, equipment and other assets, compared to a $1.2 million gain on disposition of property, equipment and other assets related to the sale of surplus land during the first half of fiscal 2025.
Corporate expenses during the second quarter of fiscal 2026 decreased $0.6 million compared to the second quarter of fiscal 2025, primarily due to decreased incentive compensation expenses, decreased professional fees related to tax, and audit, partially offset by personnel and benefits cost inflation, increased non-cash stock compensation, director compensation, and increased legal professional fees. Corporate expenses during the first half of fiscal 2026 decreased $0.2 million compared to the first half of fiscal 2025 due to decreased professional fees related to tax, audit, and legal services, and decreased incentive compensation expenses, partially offset by increased non-cash stock compensation, personnel and benefits cost inflation, and director compensation.
Our interest expense totaled $2.7 million and $5.4 million for the second quarter and first half of fiscal 2026, respectively, compared to $3.0 million and $5.8 million for the second quarter and first half of fiscal 2025, respectively. The decrease in interest expense during the second quarter and first half of fiscal 2026 was primarily due to decreased borrowings and a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.
16
Table of Contents
We recognized investment income of $0.1 million during the second quarter and first half of fiscal 2026, compared to $0.4 million and $0.5 million during the second quarter and first half of fiscal 2025, respectively. Variations in investment income were due to changes in the value of marketable securities.
We did not have any significant variations in other expenses and equity losses from unconsolidated joint ventures during the second quarter and first half of fiscal 2026, compared to the second quarter and first half of fiscal 2025.
Net earnings (loss) and net earnings (loss) per diluted common share improved during the second quarter and first half of fiscal 2026 compared to the second quarter and first half of fiscal 2025, resulting primarily from an increase in operating income as described above.
We reported income tax expense of $8.1 million for the second quarter of fiscal 2026 compared to expense of $2.7 million for the second quarter of fiscal 2025. We reported income tax expense of $0.5 million for the first half of fiscal 2026 compared to a benefit of $4.6 million for the first half of fiscal 2025. Our fiscal 2026 first half effective income tax rate was 50.8% compared to our fiscal 2025 first half effective income tax rate of 32.7%. The effective income tax rate for the first half of 2026 was negatively impacted by discrete tax items related to stock option exercises. The effective income tax rate in both fiscal 2026 first half and fiscal 2025 first half was negatively impacted by excess compensation subject to deduction limitations. We anticipate that our effective income tax rate for fiscal 2026 may be in the 32% to 34% range, excluding any potential changes in federal or state income tax rates, valuation allowance adjustments or other one-time tax benefits. Our actual fiscal 2026 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.
Theatres
The following table sets forth revenues, operating income, operating margin, Adjusted EBITDA and Adjusted EBITDA margin for our theatre division for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for variance percentage, operating margin and Adjusted EBITDA margin):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct.F2026F2025Amt.Pct.
Total revenues$150.6 $131.7 $19.0 14.4 %$243.6 $219.0 $24.6 11.2 %
Total revenues before cost reimbursements149.8 131.0 18.8 14.4 %242.1 217.5 24.5 11.3 %
Operating income26.7 15.7 11.0 69.8 %23.8 9.4 14.4 153.1 %
Operating margin(1)
17.8 %12.0 % 9.9 %4.3 % 
Adjusted EBITDA(2)
36.3 26.5 9.8 36.8 %44.3 30.2 14.1 46.6 %
Adjusted EBITDA margin(2)
24.2 %20.3 %18.3 %13.9 %
(1)Operating margin is defined as operating income divided by total revenues before cost reimbursements.
(2)Adjusted EBITDA margin is defined as Adjusted EBITDA divided by total revenues before cost reimbursements. See Adjusted EBITDA section below for further discussion and non-GAAP reconciliations.
Revenues and operating income for the Theatre division improved during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025, primarily due to increased attendance driven by stronger performances from films. Additionally, operating income in the second quarter of fiscal 2026 was favorably impacted by a $0.8 million decrease in depreciation expense and $0.3 million gain on disposition of property, equipment and other assets compared to a $0.2 million loss on disposition of property, equipment and other assets in second quarter of fiscal 2025.
During the first half of fiscal 2026, revenues and operating income increased compared to the same period in fiscal 2025 driven primarily by stronger performances from films resulting in increased attendance, partially offset by five fewer operating days in the first half of fiscal 2026 compared to the first half of fiscal 2025. The five fewer operating days in the first half of fiscal 2026 (which occurred between the Christmas and New Year’s holidays in the prior year period) negatively impacted revenue growth by $12.2 million and the change in operating income by approximately $5.0 million. Additionally, operating income in the first half of fiscal 2026 was favorably impacted by a $1.2 million decrease in depreciation expense, and a $0.2 million gain on disposition of property, equipment and other assets compared to a $1.1
17
Table of Contents
million gain on disposition of property, equipment and other assets in the first half of fiscal 2025, primarily due to sales of surplus land.
Our theatre division Adjusted EBITDA and Adjusted EBITDA margin increased during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025 driven by improved operating leverage from increased revenues and higher labor efficiency, partially offset by increased repairs & maintenance, and general administrative expenses. During the first half of fiscal 2026, theatre division Adjusted EBITDA and Adjusted EBITDA margin increased compared to the first half of fiscal 2025, due to increased revenues and improved labor efficiency, partially offset by a $5.0 million unfavorable impact from five fewer operating days and increases in insurance and general administrative expenses.
The following table provides a further breakdown of the components of revenues for the theatre division for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for variance percentage):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct.F2026F2025Amt.Pct.
Admission revenues$72.6 $62.3 $10.2 16.4 %$117.4 $103.3 $14.1 13.7 %
Concession revenues65.3 57.6 7.7 13.3 %104.8 95.6 9.2 9.6 %
Other revenues12.0 11.0 1.0 8.9 %19.8 18.6 1.2 6.5 %
Total revenues before cost
   reimbursements
149.8 131.0 18.8 14.4 %242.1 217.5 24.5 11.3 %
Cost reimbursements0.8 0.6 0.2 n/m1.5 1.5 — n/m
Total revenues150.6 131.7 19.0 14.4 %243.6 219.0 24.6 11.2 %
According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal 2026 second quarter and first half results, U.S. box office receipts increased 11.5% during our fiscal 2026 second quarter compared to our fiscal 2025 second quarter, indicating that our increase in admission revenues for comparable theatres (excluding theatres closed during the past year) of 16.6% during the second quarter of fiscal 2026 outperformed the industry by 5.1 percentage points. We believe our outperformance in the second quarter of fiscal 2026 was largely attributable to strategic pricing changes made late during the second quarter of fiscal 2025, resulting in higher average ticket price growth compared to other exhibitors. We believe our outperformance was also the result of a favorable film mix, that included family films such as The Super Mario Galaxy Movie, Toy Story 5, and Star Wars: The Mandalorian and Grogu, that were more appealing to audiences in our Midwestern markets than in other parts of the U.S.
Data received and compiled by us from Comscore also indicates that U.S. box office receipts increased 9.0% during our fiscal 2026 first half compared to the first half of fiscal 2025, indicating that our increase of 13.9% in admission revenues for comparable theatres (excluding theatres closed during the past year) during the first half of fiscal 2026, outperformed the industry by 4.9 percentage points. On a calendar date basis (January 1st through June 30th), U.S. box office receipts increased 14.9%, indicating that our increase in admissions revenues for our comparable theatres of 21.0%, outperformed the industry by 6.1 percentage points during the first half of 2026 compared to the first half of 2025, with ticket price changes and a favorable film mix contributing to this year-to-date outperformance.
Additional data received and compiled by us from Comscore indicates our admission revenues at comparable theatres during the second quarter and first half of fiscal 2026 represented approximately 3.0% of the total admission revenues in the U.S. (commonly referred to as market share in our industry), compared to 2.8% and 2.9% during the second quarter and first half of fiscal 2025, respectively. Our goal is to outperform the industry, but our ability to do so in any given quarter will likely be partially dependent upon film mix, pricing strategies, weather and the competitive landscape in our markets.
Total theatre attendance for our comparable theatres increased 10.9% during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025, which was primarily attributable to increased box office performances from films. During the second quarter of fiscal 2026, there were 31 wide-release films (films shown in over approximately 1,500 theatres in the U.S., excluding re-release films) compared to 29 wide-release films during the second quarter of fiscal 2025.
During the first half of fiscal 2026, total theatre attendance for our comparable theatres increased 7.2% compared to the first half of fiscal 2025, which was primarily attributable to increased box office performance from films and negatively
18
Table of Contents
impacted by five less operating days described above. During the first half of fiscal 2026, there were 61 wide-release films, compared to 56 wide-release films during the first half of fiscal 2025. On a calendar date basis (January 1st through June 30th), total theatre attendance for our comparable theatres increased 13.9% during the first half of 2026 compared to the first half of 2025.
Our highest grossing films during the fiscal 2026 second quarter included The Super Mario Galaxy Movie, Michael, Toy Story 5, Obsession, and Backrooms. Our top five films during our fiscal 2026 second quarter accounted for 55% of our total box office results, compared to 59% for the top five films during the second quarter of fiscal 2025, both expressed as a percentage of the total admission revenues for the relevant period. An increased reliance on just a few blockbuster films during a given quarter often has the effect of increasing our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. As a result of the less concentrated film slate, our overall film cost as a percentage of admission revenues during the second quarter of fiscal 2026 decreased compared to the same period in the prior fiscal year.
Our average ticket price increased 5.2% and 6.2% during the second quarter and first half of fiscal 2026, respectively, compared to the second quarter and first half of fiscal 2025. Our average ticket price during the second quarter and first half of fiscal 2026 was favorably impacted by strategic pricing changes and ticket mix. These increases were partially offset by a decrease in the percentage of our ticket sales coming from premium large format (PLF) screens. The overall change in average ticket price favorably impacted our admission revenues of our comparable theatres by $3.5 million and $6.9 million during the second quarter and first half of fiscal 2026, respectively, compared to the second quarter and first half of fiscal 2025.
Our average concession revenues per person increased by 2.4% and 2.6% during the second quarter and first half of fiscal 2026, respectively, compared to the second quarter and first half of fiscal 2025, resulting from increases in movie-themed merchandise sales, concessions menu prices, and the number of concessions transactions per person or incidence rate. The overall increase in average concession revenues per person favorably impacted our concession revenues of our comparable theatres by $1.5 million and $2.6 million during the second quarter and first half of fiscal 2026, respectively, compared to the second quarter and first half of fiscal 2025.
Other revenues during the second quarter and first half of fiscal 2026 increased by $1.0 million and $1.2 million, respectively, compared to the second quarter and first half of fiscal 2025, due largely to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising revenue.
We ended the second quarter of fiscal 2026 with a total of 961 company-owned screens in 76 theatres and 14 managed screens at one theatre, compared to 971 company-owned screens in 77 theatres and 14 managed screens at one theatre, at the end of the second quarter of fiscal 2025. We made the decision to close underperforming theatres during fiscal 2025 and 2026, including one leased theatre during first quarter of fiscal 2025, and one owned theatre during the second quarter of fiscal 2026.
Hotels and Resorts
The following table sets forth revenues, operating income (loss), operating margin, Adjusted EBITDA and Adjusted EBITDA margin for our hotels and resorts division for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for variance percentage, operating margin and Adjusted EBITDA margin):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct.F2026F2025Amt.Pct.
Total revenues$81.0 $74.3 $6.7 9.0 %$142.4 $135.6 $6.8 5.0 %
Total revenues before cost reimbursements70.8 64.6 6.2 9.6 %122.5 116.9 5.6 4.8 %
Operating income (loss)6.7 4.2 2.5 59.8 %(1.2)(1.9)0.6 33.7 %
Operating margin(1)
8.3 %5.6 % (0.9)%(1.4)% 
Adjusted EBITDA(2)
14.7 11.2 3.5 31.1 %14.4 12.2 2.2 17.9 %
Adjusted EBITDA margin(2)
20.8 %17.4 %11.8 %10.5 %
(1)Operating margin is defined as operating income divided by total revenues before cost reimbursements.
19
Table of Contents
(2)Adjusted EBITDA margin is defined as Adjusted EBITDA divided by total revenues before cost reimbursements. See Adjusted EBITDA section below for further discussion and non-GAAP reconciliations.
Hotels and resorts division revenues increased 9.0% during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025. Division operating income during the second quarter of fiscal 2026 increased $2.5 million compared to the second quarter of fiscal 2025 primarily due to increased revenues and improved labor efficiency. Conversely, operating income during the second quarter of fiscal 2026 was unfavorably impacted by a $0.5 million increase in depreciation expense, and a $0.4 million loss on disposition of property, equipment and other assets.
During the first half of fiscal 2026, Hotels and resorts division revenues increased 5.0% compared to the first half of fiscal 2025. Results were negatively impacted by five fewer operating days during the first half of fiscal 2026 compared to the first half of fiscal 2025. The five fewer operating days during the first half of fiscal 2026 negatively impacted revenue growth by approximately $3.1 million and operating loss by approximately $0.4 million. Operating loss improved $0.6 million during the first half of fiscal 2026, compared to the first half of fiscal 2025, due primarily to increased revenues. Operating loss during the first half of fiscal 2026 was negatively impacted by a $1.0 million increase in depreciation expense, and a $0.4 million loss on disposition of property, equipment and other assets.
Our Hotels and resorts division Adjusted EBITDA and Adjusted EBITDA margin increased during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025 due to increased revenue and improved labor efficiency. Additionally, division Adjusted EBITDA during the second quarter of fiscal 2026 was favorably impacted by reimbursement of repair costs incurred in prior year following a water damage event.
During the first half of fiscal 2026, Adjusted EBITDA and Adjusted EBITDA margin increased primarily due to increased revenues compared to the first half of fiscal 2025. Conversely, Adjusted EBITDA during the first half of fiscal 2026 was negatively impacted by approximately $0.4 million due to five fewer operating days, a decrease in other revenue related to certain group business at one of our condo hotel properties, and increases in personnel and other costs.
The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for variance percentage):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct.F2026F2025Amt.Pct.
Room revenues$33.7 $29.6 $4.1 13.7 %$54.2 $48.9 $5.3 10.8 %
Food/beverage revenues22.5 21.3 1.2 5.7 %40.0 39.1 0.8 2.2 %
Other revenues14.5 13.6 0.9 6.6 %28.3 28.8 (0.5)(1.7)%
Total revenues before cost reimbursements70.8 64.6 6.2 9.6 %122.5 116.9 5.6 4.8 %
Cost reimbursements10.2 9.7 0.5 5.2 %19.9 18.7 1.2 6.2 %
Total revenues$81.0 $74.3 $6.7 9.0 %$142.4 $135.6 $6.8 5.0 %
Division total revenues before cost reimbursements increased 9.6% during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025 due to increased occupancy at five of our seven comparable owned hotels, and strong golf revenues at Grand Geneva Resort & Spa. Division total revenues before cost reimbursements during the second quarter of fiscal 2026 were also favorably impacted by the Hilton Milwaukee being fully operational compared to the prior year period when the hotel had rooms out of service while undergoing significant renovations.
Division total revenues before cost reimbursements increased 4.8% during the first half of fiscal 2026, compared to the first half of fiscal 2025, due to increased occupancy at four of our seven comparable owned hotels, partially offset by the negative impact of five fewer operating days due to the change in fiscal year described above and decreases in other revenues driven primarily by a group buyout of one condo hotel property during a portion of the first half of 2025 that did not reoccur in the current year. Division total revenues before cost reimbursements during the first half of fiscal 2026 were favorably impacted by the Hilton Milwaukee being fully operational compared to the prior year period when the hotel had rooms out of service while undergoing significant renovations.
20
Table of Contents
The following table sets forth certain operating statistics for the second quarter and first half of fiscal 2026 and fiscal 2025, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for comparable company-owned properties:
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct. F2026F2025Amt.Pct.
Occupancy pct.73.2 %67.3 %5.9 pts8.8 %66.2 %58.6 %7.6 pts13.0 %
ADR$205.51 $196.35 $9.16 4.7 %$183.90 $181.34 $2.56 1.4 %
RevPAR$150.39 $132.07 $18.32 13.9 %$121.82 $106.22 $15.60 14.7 %
Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort.
RevPAR increased at six of our seven comparable company-owned properties during the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025, driven by both increased occupancy rates and increased average daily rates. Group business as a percentage of our mix of business represented approximately 45.2% of our total rooms revenue in the second quarter of fiscal 2026, compared to approximately 47.1% during the second quarter of fiscal 2025. Non-group transient pricing increased in most of our major markets during the second quarter of fiscal 2026, driven by strong leisure demand and continued group growth, which resulted in rate compression that increased average daily rates.
According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal 2026 second quarter and first half results, comparable “upper upscale” hotels—hotels identified as our industry— throughout the United States experienced increases in RevPAR of 5.7% and 4.8% during our second quarter and first half of fiscal 2026, respectively, compared to our second quarter and first half of fiscal 2025, leading us to believe we outperformed the industry during the second quarter and first half of fiscal 2026 by approximately 8.2 and 9.9 percentage points, respectively. We believe our outperformance during the second quarter and first half of fiscal 2026 was partially driven by the favorable impact of the Hilton Milwaukee hotel being fully operational, compared to the second quarter and first half of fiscal 2025 when the hotel was undergoing significant renovations.
Data received from Smith Travel Research for our various “competitive sets”—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced an increase in RevPAR of 7.8% during our fiscal 2026 second quarter, again compared to our fiscal 2025 second quarter. Therefore, we outperformed our competitive sets during the second quarter of fiscal 2026 by approximately 6.1 percentage points. We believe our outperformance to our competitive sets during the second quarter of fiscal 2026 resulted primarily from strong performance in our group customer segment, in particular at our renovated hotel properties, coupled with a strong start to the summer golf season at Grand Geneva Resort & Spa. We believe the outperformance to our competitive sets during the second quarter of fiscal 2026 was also partially attributable to the renovation of Hilton Milwaukee in the prior year period which we believe unfavorably impacted our RevPAR in the second quarter of fiscal 2025 while favorably impacting competitive hotels. After adjusting for the estimated impact of the Hilton Milwaukee renovation on the prior year, we believe our hotels outperformed their competitive sets during the second quarter of fiscal 2026 by approximately 1.1 percentage point. During the first half of fiscal 2026, hotels in our competitive sets experienced an increase in RevPAR of 5.3%, indicating that we outperformed our competitive set hotels by approximately 9.4 percentage points. After adjusting for the estimated impact of the Hilton Milwaukee renovation on the prior year, we believe our hotels outperformed their competitive sets during the first half of fiscal 2026 by approximately 4.6 percentage points.
We generally expect our revenue trends to track or exceed the overall industry trends for our segment of the industry, particularly in our respective markets. Hotel revenues have historically tracked very closely with traditional macroeconomic statistics, such as the Gross Domestic Product. The U.S. economic outlook remains in a period of heightened uncertainty. In the near term, we expect business travel demand and our group business to remain stable. Leisure travel demand has softened in the midscale and economy segments of the market, while generally remaining stable in the upper upscale segment of the market that includes most of our properties. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder in our primarily Midwestern markets.
21
Table of Contents
As of the date of this report, our group room revenue bookings for fiscal 2026 - commonly referred to in the hotels and resorts industry as “group pace” - is running approximately 3% ahead of where we were at the same time last year. Group room revenue bookings for fiscal 2027 is running approximately 9% ahead of where we were at the same time in fiscal 2025 for fiscal 2026. Banquet and catering revenue pace for fiscal 2026 is running approximately 4% ahead of where we were at the same time last year. Banquet and catering revenue pace for fiscal 2027 is running approximately 9% ahead of where we were at the same time in fiscal 2025 for fiscal 2026.
Adjusted EBITDA
Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.
We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, impairment charges, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes, depreciation and amortization and non-cash share-based compensation expense, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.
The following table sets forth Adjusted EBITDA by reportable operating segment for the second quarter and first half of fiscal 2026 and fiscal 2025 (in millions, except for variance percentage):
Second QuarterFirst Half
VarianceVariance
F2026F2025Amt.Pct. F2026F2025Amt.Pct.
Theatres$36.3 $26.5 $9.8 36.8 %$44.3 $30.2 $14.1 46.6 %
Hotels and resorts14.7 11.2 3.5 31.1 %14.4 12.2 2.2 17.9 %
Corporate items(4.9)(5.5)0.6 11.6 %(10.0)(10.5)0.5 4.4 %
Total Adjusted EBITDA$46.2 $32.3 $13.9 43.0 %$48.8 $32.0 $16.7 52.3 %
22
Table of Contents
The following table sets forth our reconciliation of Adjusted EBITDA (in millions):
Second QuarterFirst Half
F2026F2025F2026F2025
Net earnings (loss)$15.8 $7.3 $0.5 $(9.5)
Add (deduct):
Investment (income)(0.1)(0.4)(0.1)(0.5)
Interest expense2.7 3.0 5.4 5.8 
Other (income) expense0.4 0.4 0.8 0.9 
Loss (gain) on disposition of property, equipment and other assets0.1 0.2 0.2 (1.2)
Equity (earnings) losses from unconsolidated joint ventures— (0.1)0.7 0.5 
Income tax expense (benefit)8.1 2.7 0.5 (4.6)
Depreciation and amortization17.4 17.6 35.2 35.4 
Share-based compensation expenses (1)
1.6 1.4 5.5 5.0 
Theatre exit costs (2)
— — — 0.1 
  Other non-recurring (3)
— — 0.1 — 
Total Adjusted EBITDA$46.2 $32.3 $48.8 $32.0 
The following tables set forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):
Second Quarter, F2026First Half, F2026
TheatresHotels & ResortsCorp. ItemsTotalTheatresHotels & ResortsCorp. ItemsTotal
Operating income (loss)$26.7 $6.7 $(6.3)$27.1 $23.8 $(1.2)$(14.8)$7.8 
Depreciation and amortization9.7 7.3 0.4 17.4 20.0 14.5 0.8 35.2 
Loss (gain) on disposition of property, equipment and other assets(0.3)0.4 — 0.1 (0.2)0.4 — 0.2 
Share-based compensation (1)
0.2 0.3 1.1 1.6 0.7 0.7 4.1 5.5 
Other non-recurring (3)
— — — — — 0.1 — 0.1 
Total Adjusted EBITDA$36.3 $14.7 $(4.9)$46.2 $44.3 $14.4 $(10.0)$48.8 
Second Quarter, F2025First Half, F2025
TheatresHotels & ResortsCorp. ItemsTotalTheatresHotels & ResortsCorp. ItemsTotal
Operating income (loss)$15.7 $4.2 $(6.9)$13.0 $9.4 $(1.9)$(15.0)$(7.4)
Depreciation and amortization10.5 6.7 0.4 17.6 21.2 13.5 0.8 35.4 
Loss (gain) on disposition of property, equipment and other assets0.2 — — 0.2 (1.2)— — (1.2)
Share-based compensation (1)
0.2 0.3 1.0 1.4 0.7 0.6 3.7 5.0 
Theatre exit costs (2)
— — — — 0.1 — — 0.1 
Total Adjusted EBITDA$26.5 $11.2 $(5.5)$32.3 $30.2 $12.2 $(10.5)$32.0 
(1)Non-cash expense related to share-based compensation programs.
(2)Reflects non-recurring costs related to the closure and exit of one theatre location in the first quarter of fiscal 2025.
(3)Other non-recurring includes professional fees related to the sale of historic tax credits resulting from the renovation at Hilton Milwaukee.

23
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
Liquidity
Our movie theatre and hotels and resorts businesses each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment’s revenue is derived predominantly from consumer cash purchases. We believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses. However, our cash position may fluctuate from time-to-time based on seasonality of our businesses, the timing of interest payments on our debt as well as timing of payment of other operating expenses that are paid on an infrequent basis.
Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our 90-year history and our financial position remains strong. As of June 30, 2026, we had a cash balance of approximately $26.3 million, $219.3 million of availability under our $225 million revolving credit facility, our debt-to-capitalization ratio was 0.25, and our net leverage ratio was 1.14x net debt to Adjusted EBITDA. With our strong liquidity position combined with cash generated from operations, we believe we have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial statements, as well as fund our longer-term capital requirements.
The following table sets forth our reconciliations of Net Debt and Net Leverage (Net Debt to Adjusted EBITDA) (in millions, except leverage ratio):
June 30, 2026December 31, 2025
Long-term debt (GAAP measure) (1)
$149.1 $159.0 
Finance lease obligations (GAAP measure) (2)
10.0 11.3 
Less: Cash and cash equivalents(26.3)(23.4)
Net Debt$132.7 $146.8 
Net Debt$132.7 $146.8 
LTM Adjusted EBITDA (3)
116.0 99.3 
Net Leverage (Net Debt to Adjusted EBITDA)1.14x1.48x
(1)Represents total long-term debt, including the current portion of long-term debt.
(2)Represents total finance lease obligations, including the current portion of finance lease obligations.
(3)LTM Adjusted EBITDA is Adjusted EBITDA as reconciled and defined above for the last four fiscal quarters.

We believe Net Leverage is a useful measure, as it provides management and investors an indication of our indebtedness less unrestricted cash relative to our earnings performance.
Financial Condition
Net cash provided by operating activities totaled $38.7 million during the first half of fiscal 2026, compared to net cash used in operating activities of $3.7 million during the first half of fiscal 2025. The $42.4 million increase in net cash provided by operating activities was primarily due to a $10.7 million favorable impact from the timing of payments of accounts payable, a $5.0 million decrease in prepaid and other assets, a $6.8 million increase in accrued compensation, $3.0 million in proceeds from the sale of historic tax credits, and a $10.0 million increase in net earnings.
Net cash used in investing activities during the first half of fiscal 2026 totaled $16.5 million, compared to net cash used in investing activities of $31.5 million during the first half of fiscal 2025. The decrease in net cash used in investing activities of $15.1 million was the result of a decrease of $23.3 million in capital expenditures, partially offset by a $8.2 million decrease in proceeds from the sale of trading securities in the prior year that did not recur. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled $16.6 million during the first half of fiscal 2026 compared to $39.9 million during the first half of fiscal 2025.
24
Table of Contents
Fiscal 2026 first half cash capital expenditures included approximately $10.1 million incurred in our theatre division, including construction related to insured property damage at one theatre location, and normal maintenance capital projects. We incurred capital expenditures in our hotels and resorts division during the first half of fiscal 2026 of approximately $6.2 million, including several smaller capital improvement projects and normal maintenance capital projects. We incurred corporate capital expenditures during the first half of fiscal 2026 of approximately $0.3 million related to technology implementation.
Net cash used in financing activities during the first half of fiscal 2026 totaled $17.9 million compared to net cash provided by financing activities of $7.4 million during the first half of fiscal 2025. During the first half of fiscal 2026, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added $82.0 million of new short-term revolving credit facility borrowings, and we made $92.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2026 (net $10.0 million decrease in borrowings on our credit facility). We ended the second quarter of fiscal 2026 with no outstanding borrowings under our revolving credit facility. During the first half of fiscal 2025, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added $105.0 million of new short-term revolving credit facility borrowings, and we made $84.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2025 (net $21.0 million increase in borrowings on our credit facility).
Our debt-to-capitalization ratio (excluding our finance and operating lease obligations) was 0.25 at June 30, 2026, compared to 0.26 at December 31, 2025.
During the first half of fiscal 2026, we repurchased 0.1 million shares of our common stock for $1.3 million in the open market, compared to 0.4 million shares of our common stock for $7.1 million in the open market during the first half of fiscal 2025. As of June 30, 2026, approximately 4.4 million shares remained available for repurchase under prior Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.
Dividends paid during the first half of fiscal 2026 were $4.8 million. Dividends paid during the first half of fiscal 2025 were $4.3 million. We have the ability to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.
Critical Accounting Policies and Estimates
We have included a summary of our Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to the summary provided in that report.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We have not experienced any material changes in our market risk exposures since December 31, 2025.
Item 4. Controls and Procedures
a.Evaluation of disclosure controls and procedures
Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
b.Changes in internal control over financial reporting
There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by
25
Table of Contents
this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
26
Table of Contents
PART II – OTHER INFORMATION
Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.
PeriodTotal Number of
Shares
Purchased		Average Price
Paid per Share		Total Number of
Shares
Purchased as
Part of Publicly
Announced
Programs (1)		Maximum
Number of
Shares that May
Yet be Purchased
Under the Plans
or Programs (1)
 April 1 - April 30 369 $18.41 369 4,395,313 
 May 1 - May 31 12,218 18.61 12,218 4,383,095 
 June 1 - June 30 — — — 4,383,095 
  Total12,587 $18.60 12,587 4,383,095 
(1)Through June 30, 2026, our Board of Directors had authorized the repurchase of up to approximately 15.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of June 30, 2026, we had repurchased approximately 11.3 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit, option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date.
Item 4. Mine Safety Disclosures
Not applicable.

Item 5. Other Information

During the three months ended June 30, 2026, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
31.1
Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32
Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.
101.INSThe instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
27
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE MARCUS CORPORATION
DATE: July 30, 2026
By: /s/ Gregory S. Marcus
Gregory S. Marcus
President and Chief Executive Officer
DATE: July 30, 2026
By: /s/ Chad M. Paris
Chad M. Paris
Chief Financial Officer and Treasurer
S-1

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com